| | Carisbamate Shows Antiepileptic Efficacy; Phase III Studies PlannedPHILADELPHIA — Carisbamate, a new antiepileptic drug, showed safety and efficacy in a phase II study with more than 500 patients. PII: S1553-3212(08)70041-4 doi:10.1016/S1553-3212(08)70041-4 © 2008 Elsevier Inc. All rights reserved. | |
|
|